Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yaowen Zhang"'
Autor:
Chenyu Wang, Linzhi Jin, Xinyu Cheng, Runchuan Ren, Anping Zheng, Anlin Hao, Nengchao Wang, Jinwen Zhang, Fuyou Zhou, Yaowen Zhang
Publikováno v:
BioMed Research International. 2022:1-9
This study is aimed at assessing the sintilimab-based regimens’ safety and efficacy for advanced esophageal cancer (EC) treatment in the real world. Cases of advanced EC treated with sintilimab-based regimens in the Anyang Tumor Hospital between 1
Autor:
Bo Yang, Xiaofeng Guo, Cheng Le, Wenzhong Su, Xiaoming Li, Yanfeng Zhang, Guangyi Yang, Weimin Liang, Zhixin Zheng, Junpeng Wu, Yaowen Zhang, Anlin Hao
Publikováno v:
BioMed Research International. 2022:1-9
Evidence for neoadjuvant chemotherapy combined with targeted therapy for locally advanced esophageal squamous cancer (ESCC) is inadequate. We conducted a single-arm phase II trial to evaluate the efficacy and safety of apatinib combined with taxol an
Autor:
Chenyu Wang, Xinyu Cheng, Linzhi Jin, Runchuan Ren, Shaohua Wang, Anping Zheng, Anlin Hao, Fuyou Zhou, Yaowen Zhang
Publikováno v:
BioMed Research International. 2022:1-8
This study aims to develop and validate a effective prognostic nomogram for locally advanced esophageal squamous cell carcinoma (LA-ESCC) patients undergoing concurrent chemoradiotherapy (CCRT). Retrospective analysis of 503 patients with LA-ESCC giv
Autor:
Xiaopeng Wang, Yiwen Liu, Yannan Lu, Simo Chen, Yaoping Xing, Haijun Yang, Xiaojun Wang, Yaowen Zhang, Tao Pan, Junkuo Li, Min Wang, Ning Zhang, Mengxia Liang, Fuyou Zhou
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 51-62 (2022)
Annals of Medicine
article-version (VoR) Version of Record
Annals of Medicine
article-version (VoR) Version of Record
Background To analyze the correlation between the inducing effect of Fusobacterium nucleatum (Fn) on the surface expression of the inhibitory receptor KIR2DL1 on CD8+ T cells in oesophageal squamous cell carcinoma (ESCC) and the clinicopathological f
Autor:
Gang Wang, Narasimha M. Beeraka, Wenjing Xiao, Yaowen Zhang, Nannan Xue, Gongan Chen, Junqi Liu, Yang Liu
Publikováno v:
Technology in cancer researchtreatment. 21
Objective: Radiotherapy or chemoradiotherapy has been preferred as the clinical therapeutic modalities to combat locally advanced esophageal squamous cell carcinoma (ESCC). The aim of this retrospective study is to ascertain combinatorial efficacy of
Publikováno v:
Biochemical and Biophysical Research Communications. 519:497-504
Emerging evidence has uncovered the extremely important roles of long noncoding RNAs (lncRNAs) in the progression of malignant tumors which includes numerous processes of gene regulation. LncRNA NR2F1-AS1 has been confirmed to have close correlation
Autor:
Runchuan Ren, Ronggang Sun, Shangwen Dong, Yaowen Zhang, Qiang Zhang, Xiao Huang, Anping Zheng, Zhiyong Zheng, Huitao Wang
Publikováno v:
Medical Dosimetry. 44:167-172
Background The new TomoDirect (TD) modality offers a nonrotational option with discrete beam angles. We aim to compare dosimetric parameters of TD, helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), and fixed-field intensity-modulated
Autor:
Peng Han, Jiangman Zhao, Fuyou Zhou, Weilan Yuan, Jian Li, Ningtao Dai, Jianpo Wang, Yaowen Zhang, Jiahuan Zhou
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Background To investigate the differences in plasma metabolomic characteristics between pathological complete response (pCR) and non-pCR patients and identify biomarker candidates for predicting the response to neoadjuvant chemoradiotherapy (nCRT) in
Publikováno v:
Functionalintegrative genomics. 21(3-4)
Esophageal carcinoma (EC) is a tremendous threat to human health and life worldwide. Long non-coding RNAs (lncRNAs) have been identified as crucial players in carcinomas including EC. An in-depth understanding on regulatory networks of lncRNAs contri
Autor:
YAOWEN ZHANG1, SHANGWEN DONG2, RUIPING XU1, YANPING YANG1, ZHIYONG ZHENG1, XIAOJING WANG1, RUNCHUAN REN1, RONGGANG SUN1, MING LI1, HAIJUN YANG1, YUTING HUANG3, FUYOU ZHOU1 ayzhoufuyou@163.com, ANPING ZHENG1 zhenganping3@126.com
Publikováno v:
Oncology Letters. Apr2017, Vol. 13 Issue 4, p2549-2556. 8p.